CHINA ISOTOPE & RADIATION CORPORATION China Isotope & Radiation Corporation
Equities
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.08 HKD | -2.33% |
|
-1.37% | -24.55% |
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.55% | 413M | |
| -10.24% | 11.24B | |
| -13.76% | 7.29B | |
| +29.50% | 5.57B | |
| -19.19% | 3.68B | |
| +7.62% | 2.58B | |
| -65.24% | 2.33B | |
| -10.48% | 2.23B | |
| +27.80% | 2.21B | |
| -19.12% | 1.57B |
- Stock Market
- Equities
- 1763 Stock
- News China Isotope & Radiation Corporation
- China Approves CIRC's Tomography Supporting Therapy Planning System
